Categories Analysis, Earnings, Retail

American Eagle might see strength in comps

American Eagle Outfitters (AEO) is scheduled to report its second quarter 2018 earnings results on August 29. For the first quarter, the company beat market expectations with an 8% increase in revenues and a 58% increase in profits.

For the second quarter, American Eagle expects earnings to come in the range of $0.27 to $0.29 per share. Wall Street appears to have a bit more faith and expects the company to achieve earnings of $0.30 per share, reflecting a year-over-year growth of more than 57%. Analysts expect the topline to grow around 11% year-over-year to around $945 million.

The solid results in the first quarter were driven by a 9% increase in comparable store sales, with particular strength seen in the Aerie brand. The good comp performance, which was driven by an appealing assortment of merchandise as well as solid operational execution last time, is expected to continue for this quarter too, with an increase projected in the mid-single digits range.

Comparable store sales are expected to increase in the mid-single digits range

Last quarter American Eagle witnessed growth in traffic and transactions. The company also saw strength across all its channels which helped boost the comp performance.

Although there is tough competition in the retail sector, American Eagle is investing significantly in both its stores and digital channels and these are expected to drive increases in revenues and profits for this quarter too.

American Eagle comp sales trend

Several retailers have reported positive results this quarter. Earlier this month, Macy’s Inc. (M) reported Q2 earnings results which beat market expectations. Macy’s stock, however, dropped 5% following its results release.

American Eagle stock is up 51% thus far this year and up 23% over the past three months.

Related: American Eagle Q1 2018 Earnings Infographic

American Eagle Outfitters first quarter 2018 earnings

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top